Clinical Trials and Research: Ensuring Patients and Researchers’ Values Align
Over the years, patients have been seen and tagged as subjects in research. More recently, there has been a shift to the use of more preferable terms such as partner or stakeholder in research; but are we there yet?
There is still a lot that needs to be done to ensure appropriate visibility of patients participating in clinical trials and research
On November 4th, Join a panel of clinician-researcher, individuals living with sickle cell disease, and industry partners at 3 PM EST in a candid discussion on diversity, equity, inclusion, and value alignment when it comes to clinical trials and research.
This session would be moderated by Mrs. Lanre Tunji-Ajayi, the president/CEO of the Sickle Cell Awareness Group of Ontario, and Dr. Dawn Richards, the Director of Public Engagement at the Clinical Trials Ontario. You do not want to miss this session!
